NASDAQ:ALT | Free Cash Flow | Altimmune, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$20.94M$21,000.00-$20.96M
2025-12-31-$19.45M$1,000.00-$19.45M
2025-03-31-$16.84M
2024-12-31-$18.27M
2024-03-31-$16.36M
2023-12-31-$16.53M$0.00-$16.53M
2023-03-31-$19.41M$51,000.00-$19.46M
2022-12-31-$17.31M$38,000.00-$17.34M
2022-03-31-$13.53M$9,000.00-$13.54M
2021-12-31-$21.97M$147,000.00-$22.11M
2021-03-31-$19.57M$4.21M-$23.78M
2020-12-31-$13.28M$103,628.00-$13.39M
2020-03-31-$4.35M$18,131.00-$4.37M
2019-12-31-$2M$0.00-$2M
2019-03-31-$2.11M$1,226.00-$2.11M
2018-12-31-$5.16M$7,053.00-$5.16M
2018-03-31-$3.56M$652,635.00-$4.21M
2017-12-31-$4.81M$22,592.00-$4.83M
2017-03-31-$3.34M$39,582.00-$3.38M
2016-12-31-$1.49M$11,915.00-$1.5M
2016-03-31-$1.36M$150.00-$1.36M
2015-12-31-$1.83M$18,230.00-$1.85M
2015-03-31-$2.71M$35,352.00-$2.75M-187.83%
2014-12-31-$3.52M$0.00-$3.52M
2014-03-31-$2.29M$37,050.00-$2.33M
2013-12-31-$6.26M$0.00-$6.26M
2013-03-31$260,401.00$25,468.00$234,933.00
2012-12-31-$2.15M
2012-03-31$791,370.00
2011-12-31-$805,132.00$0.00-$805,132.00-107.47%
2011-03-31-$2.09M
2010-12-31-$6.72M$50,002.00-$6.77M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$67.54M$11,000.00-$67.55M
2024-12-31-$79.85M
2023-12-31-$75.81M$47,000.00-$75.86M
2022-12-31-$62.59M$126,000.00-$62.71M
2021-12-31-$78.24M$12.12M-$90.36M
2020-12-31-$34.31M$203,957.00-$34.51M
2019-12-31-$9.6M$1,227.00-$9.6M
2018-12-31-$9.39M$975,407.00-$10.36M
2017-12-31-$20.21M$112,441.00-$20.33M
2016-12-31-$6.35M$124,955.00-$6.48M
2015-12-31-$3.22M$86,507.00-$3.3M
2014-12-31-$8.47M$92,269.00-$8.57M
2013-12-31-$7.17M$84,579.00-$7.25M
2012-12-31-$2.32M
2011-12-31-$7.81M$71,439.00-$7.88M
2010-12-31-$14.86M$374,581.00-$15.24M